EYEPOINT PHARMACEUTICALS INC. - COMMON STOCK
5.6800
23-May-25 13:45:00
15 minutes delayed
Stocks
+0.0800
+1.43%
Today's range
5.4550 - 5.7000
ISIN
N/A
Source
NASDAQ
-
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
16 May 2025 04:00:00 By Nasdaq GlobeNewswire
-
EyePoint Announces Participation at Upcoming Investor Conferences
13 May 2025 04:00:00 By Nasdaq GlobeNewswire
-
EyePoint Reports First Quarter 2025 Financial Results and Highlights Recent Corporate Developments
07 May 2025 04:00:00 By Nasdaq GlobeNewswire
-
EyePoint to Report First Quarter 2025 Financial Results on May 7, 2025
30 Apr 2025 04:00:00 By Nasdaq GlobeNewswire
-
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
16 Apr 2025 04:00:00 By Nasdaq GlobeNewswire
-
EyePoint to Present at 2025 RBC Capital Markets Ophthalmology Virtual Conference
27 Mar 2025 04:00:00 By Nasdaq GlobeNewswire
-
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
17 Mar 2025 04:00:00 By Nasdaq GlobeNewswire
-
05 Mar 2025 04:00:00 By Nasdaq GlobeNewswire
-
EyePoint Announces Participation at Upcoming Investor Conferences
04 Mar 2025 04:00:00 By Nasdaq GlobeNewswire
-
EyePoint to Report Fourth Quarter and Full-Year 2024 Financial Results on March 5, 2025
26 Feb 2025 04:00:00 By Nasdaq GlobeNewswire
-
EyePoint to Present Corporate Update at TD Cowen 45th Annual Health Care Conference
25 Feb 2025 04:00:00 By Nasdaq GlobeNewswire
-
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
17 Feb 2025 04:00:00 By Nasdaq GlobeNewswire
-
05 Feb 2025 04:00:00 By Nasdaq GlobeNewswire
-
EyePoint to Present at Guggenheim SMID Cap Biotech Conference
30 Jan 2025 04:00:00 By Nasdaq GlobeNewswire
-
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
16 Jan 2025 04:00:00 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >